By the numbers: Synchrony Financial posted strong results in its Q1 2022 earnings, per a press release.
Key context: Synchrony’s performance, which aligns with double-digit growth that other banks also saw in Q1 2022, is likely a reflection of the overall US economy. US retail and food sales grew 6.9% in March alone, per the Census Bureau. This likely combined with rising gas prices—a common rewards category on co-brand cards—and relaxed COVID-19 restrictions to drive spending.
What else is driving growth? Synchrony also notched strong growth in two other areas:
The big takeaway: Synchrony has ramped up investments and offerings in key areas, which should position it for growth through this year.
In December, Synchrony invested in one-click checkout provider Skipify and announced plans to bring it to merchant partners. It also revamped the PayPal co-brand earlier this month, which could boost engagement and attract customers. And it delved into buy now, pay later (BNPL) through partnerships with Fiserv and Mastercard, which could boost its digital volume and spending.
It’s also added to its healthcare portfolio through a partnership with Walgreens that includes a prepaid debit card, store card, and co-branded card that debuted last year. And it expanded CareCredit, which provides healthcare and veterinary financing through partnerships like a tie-up with major health system Mercyhealth to offer installment payments.
Go deeper: Read our “Co-Brand Credit Card Report” to learn more about Synchrony’s offerings and how digital cards represent the future of co-branded products.